For the quarter ended September 2024, IQVIA Holdings (IQV) reported income of $3.9 billion, up 4.3% over the identical interval final yr. EPS got here in at $2.84, in comparison with $2.49 within the year-ago quarter.
The reported income represents a shock of +1.11% over the Zacks Consensus Estimate of $3.85 billion. With the consensus EPS estimate being $2.81, the EPS shock was +1.07%.
Whereas buyers intently watch year-over-year adjustments in headline numbers — income and earnings — and the way they examine to Wall Avenue expectations to find out their subsequent plan of action, some key metrics at all times present a greater perception into an organization’s underlying efficiency.
As these metrics affect top- and bottom-line efficiency, evaluating them to the year-ago numbers and what analysts estimated helps buyers challenge a inventory’s value efficiency extra precisely.
Right here is how IQVIA carried out within the simply reported quarter when it comes to the metrics most generally monitored and projected by Wall Avenue analysts:
- Backlog: $31.1 billion in comparison with the $31.31 billion common estimate based mostly on two analysts.
- Revenues- Know-how & Analytics Options: $1.55 billion in comparison with the $1.49 billion common estimate based mostly on six analysts. The reported quantity represents a change of +8.6% yr over yr.
- Revenues- Analysis & Growth Resolution: $2.16 billion versus the six-analyst common estimate of $2.19 billion. The reported quantity represents a year-over-year change of +1.9%.
- Revenues- Contract Gross sales & Medical Options: $180 million versus $176.87 million estimated by six analysts on common. In comparison with the year-ago quarter, this quantity represents a -1.6% change.
- Phase Revenue- Know-how & Analytics Resolution: $405 million versus $364.08 million estimated by 4 analysts on common.
- Phase Revenue- Contract Gross sales & Medical Options: $12 million in comparison with the $19.06 million common estimate based mostly on 4 analysts.
- Phase Revenue- Analysis & Growth Options: $405 million in comparison with the $517.57 million common estimate based mostly on 4 analysts.
View all Key Company Metrics for IQVIA here>>>
Shares of IQVIA have returned -6.8% over the previous month versus the Zacks S&P 500 composite’s +1% change. The inventory presently has a Zacks Rank #3 (Maintain), indicating that it might carry out consistent with the broader market within the close to time period.
5 Shares Set to Double
Every was handpicked by a Zacks knowledgeable because the #1 favourite inventory to achieve +100% or extra in 2024. Whereas not all picks may be winners, earlier suggestions have soared +143.0%, +175.9%, +498.3% and +673.0%.
Many of the shares on this report are flying underneath Wall Avenue radar, which offers a fantastic alternative to get in on the bottom ground.
Today, See These 5 Potential Home Runs >>
IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
